3-186853249-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004797.4(ADIPOQ):āc.191A>Gā(p.Glu64Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,608,306 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 33)
Exomes š: 0.000066 ( 0 hom. )
Consequence
ADIPOQ
NM_004797.4 missense
NM_004797.4 missense
Scores
1
11
7
Clinical Significance
Conservation
PhyloP100: 1.71
Genes affected
ADIPOQ (HGNC:13633): (adiponectin, C1Q and collagen domain containing) This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADIPOQ | NM_004797.4 | c.191A>G | p.Glu64Gly | missense_variant | 2/3 | ENST00000320741.7 | NP_004788.1 | |
ADIPOQ-AS1 | NR_046662.2 | n.2216-7T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | |||||
ADIPOQ | NM_001177800.2 | c.191A>G | p.Glu64Gly | missense_variant | 3/4 | NP_001171271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADIPOQ | ENST00000320741.7 | c.191A>G | p.Glu64Gly | missense_variant | 2/3 | 1 | NM_004797.4 | ENSP00000320709 | P1 | |
ADIPOQ | ENST00000444204.2 | c.191A>G | p.Glu64Gly | missense_variant | 3/4 | 1 | ENSP00000389814 | P1 | ||
ADIPOQ-AS1 | ENST00000422718.1 | n.2087-7T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152276Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152276
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000297 AC: 7AN: 235650Hom.: 0 AF XY: 0.0000548 AC XY: 7AN XY: 127664
GnomAD3 exomes
AF:
AC:
7
AN:
235650
Hom.:
AF XY:
AC XY:
7
AN XY:
127664
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000659 AC: 96AN: 1456030Hom.: 0 Cov.: 32 AF XY: 0.0000622 AC XY: 45AN XY: 724020
GnomAD4 exome
AF:
AC:
96
AN:
1456030
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
724020
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74388
GnomAD4 genome
AF:
AC:
5
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 19, 2017 | The E64G variant in the ADIPOQ gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The E64G variant is observed in 3/39692 (0.007%) alleles from individuals of non-Finnish European background in the ExAC dataset (Lek et al., 2016). The E64G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret E64G as a variant of uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
T;T
Polyphen
P;P
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 23
Find out detailed SpliceAI scores and Pangolin per-transcript scores at